Skip to main content
Equibles

Candriam S.C.A.

Position in RARE — Ultragenyx Pharmaceutical Inc.

CIK 1537014 STRASSEN, N4
Back to RARE Full portfolio

Position in RARE

as of Jun 30, 2026 · filed Aug 13, 2026
Position Value
$33,451,470
+$10,486,458 QoQ
Shares Held
1,001,841
-8.6% QoQ
Ownership
1.02%
of shares outstanding
% of Portfolio
0.15%
of 13F equity value
Holder Rank
#23
of 311 holders
Holding Since
Mar 2020
24 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in RARE Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

Candriam S.C.A. holds $2,107,868,027 across 75 Biotechnology names. RARE ranks #22 (1.6% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 REGN
Regeneron Pharmaceuticals, Inc.
 195,674 $122,010,565
2 RVMD
Revolution Medicines, Inc.
 556,392 $104,201,093
3 VRTX
Vertex Pharmaceuticals Inc / Ma
 199,505 $99,100,118
4 ALNY
Alnylam Pharmaceuticals, Inc.
 314,512 $94,677,547
5 ONC
BeOne Medicines Ltd.
 289,735 $82,565,782
6 COGT
Cogent Biosciences, Inc.
 2,088,369 $80,819,880
7 ARGX
Argenx SE
 80,120 $74,332,932
8 ROIV
Roivant Sciences Ltd.
 1,990,510 $70,444,148

All Filings in RARE

Export CSV
24 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $33,451,470 1,001,841
2026-03-31 $22,965,012 1,096,182
2025-12-31 $18,385,832 799,384
2025-09-30 $22,701,797 754,714
2025-06-30 $19,135,068 526,267
2025-03-31 $26,361,495 728,017
2024-12-31 $28,365,991 674,257
2024-09-30 $39,612,260 713,092
2024-06-30 $28,315,516 688,942
2024-03-31 $24,166,603 517,597
2023-12-31 $7,100,313 148,480
2023-09-30 $1,763,962 49,480
2023-06-30 $2,282,512 49,480
2023-03-31 $2,431,463 60,635
2022-12-31 $2,292,408 49,480
2022-09-30 $2,048,966 49,480
2022-06-30 $2,951,976 49,480
2022-03-31 $3,593,237 49,480
2021-12-31 $4,160,773 49,480
2021-09-30 $4,462,601 49,480
2021-06-30 $4,717,918 49,480
2021-03-31 $11,207,125 98,429
2020-12-31 $13,625,526 98,429
2020-03-31 $5,398,245 121,500